|
ABHD5 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.76603176527124E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.00781663201633E-12 |
| Normal-vs-Stage2 |
2.828400E-04 |
| Normal-vs-Stage3 |
1.53209667175247E-11 |
| Normal-vs-Stage4 |
3.80473430539041E-13 |
| Stage1-vs-Stage2 |
2.936200E-01 |
| Stage1-vs-Stage3 |
3.681800E-01 |
| Stage1-vs-Stage4 |
2.499600E-03 |
| Stage2-vs-Stage3 |
1.360760E-01 |
| Stage2-vs-Stage4 |
7.364100E-03 |
| Stage3-vs-Stage4 |
5.421700E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.57411886145564E-14 |
| Normal-vs-AfricanAmerican |
5.16700000008363E-07 |
| Normal-vs-Asian |
4.27240000044904E-08 |
| Caucasian-vs-AfricanAmerican |
3.263400E-01 |
| Caucasian-vs-Asian |
7.583200E-01 |
| AfricanAmerican-vs-Asian |
5.354000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.21590515433923E-11 |
| Normal-vs-Female |
3.77142761465166E-12 |
| Male-vs-Female |
2.452600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.60670041107858E-10 |
| Normal-vs-Age(41-60Yrs) |
9.47575351517571E-13 |
| Normal-vs-Age(61-80Yrs) |
2.54059995263844E-09 |
| Normal-vs-Age(81-100Yrs) |
6.036600E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.444200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.393600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.332600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.595000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.713600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.733200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
8.675800E-01 |
| Classical-VS-Follicular |
4.003000E-01 |
| Classical-VS-Other |
9.565000E-01 |
| Classical-VS-Normal |
1.66966440673377E-12 |
| Tall-VS-Follicular |
4.461600E-01 |
| Tall-VS-Other |
9.931800E-01 |
| Tall-VS-Normal |
8.30640000004657E-07 |
| Follicular-VS-Other |
7.479800E-01 |
| Follicular-VS-Normal |
2.51750000002104E-06 |
| Other-VS-Normal |
1.054830E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.18970389095807E-11 |
| Normal-vs-N1 |
1.88539961420986E-10 |
| N0-vs-N1 |
1.716180E-01 |
|
|
